Brief: FDA Approves Celcuity's Gedatolisib for Advanced Breast Cancer
14/07/2026 20:26
BRIEF-FDA Approves Celcuity's Gedatolisib for Advanced Breast Cancer July 15 (Reuters) - FDA:
FDA: APPROVES GEDATOLISIB WITH FULVESTRANT, WITH OR WITHOUT PALBOCICLIB, FOR HR-POSITIVE, HER2-NEGATIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Source text: [ID:]
Further company coverage: CELC.O
((Reuters.Briefs@thomsonreuters.com;;))